Single-atom cobalt anchored biochar/PVDF membrane for antibiotic removal via coupling membrane filtration and sulfate-based advanced oxidation processes
Environmental Research · 2025-10 · 282 · 122097
DOI: 10.1016/j.envres.2025.122097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Research, 2025-10. Verfasst von Huanxin Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Environmental and Safety Engineering, Shenyang University of Chemical Technology, Shenyang, 110142, China; Shenyang Key Laboratory of Chem…. Hauptthemen laut MEDLINE: Charcoal, Membranes, Artificial, Cobalt, Anti-Bacterial Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Liaoning Revitalization Talents Program, Shenyang Science and Technology Bureau, Department of Education of Liaoning Province.
Abstract (Originalsprache)
Currently, the treatment of antibiotic-contaminated wastewater remains a serious challenge. In this study, a novel catalytic membrane, PVDF-CG@5%Co, combining polyvinylidene fluoride (PVDF), coffee grounds derived biochar (CG), and single-atom cobalt was developed for the effective removal of antibiotics from wastewater. The catalytic membranes were fabricated by phase inversion method, integrating sulfate radical-based advanced oxidation processes (SR-AOPs) with membrane filtration to address the limitations of traditional treatment methods. CG acted as the "bridging structure" which provides active sites for stable loading of single-atom catalysts (SACs) and also forms a strong interfacial bond with PVDF. The PVDF-CG@5%Co membrane exhibited excellent performance in tetracycline (TC) removal. Under optimized conditions (applied pressure 1 × 10-2 MPa, 1.125 mM peroxymonosulfate (PMS)), the PVDF-CG@5%Co membrane can achieve 90% TC removal in 10 min, which is much higher than that of filtration alone, SR-AOPs alone, and their combined effects. The membrane exhibited effective fouling resistance and good stability over a long operation period, maintaining 83.7% flux retention after 60 min running with the existence of natural organic matter (humic acid) and displayed strong stability during continuous operation. This study provides an innovative solution for antibiotic wastewater treatment and offers valuable insights into the design and development of SR-AOP-based catalytic membrane.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Environmental and Safety Engineering, Shenyang University of Chemical Technology, Shenyang, 110142, China; Shenyang Key Laboratory of Chemical Pollution Control, Shenyang University of Chemical Technology, Sh…
- College of Environmental and Safety Engineering, Shenyang University of Chemical Technology, Shenyang, 110142, China.
Förderung
- Liaoning Revitalization Talents Program
- Shenyang Science and Technology Bureau
- Department of Education of Liaoning Province
- Scientific Research Fund of Liaoning Provincial Education Department
- Shenyang University of Chemical Technology
Zitieren
APA
Zhao, H., Zhang, Z., Yu, H., Wu, D., Wang, H., & Zhang, X. (2025). Single-atom cobalt anchored biochar/PVDF membrane for antibiotic removal via coupling membrane filtration and sulfate-based advanced oxidation processes. Environmental Research, 282, 122097. https://doi.org/10.1016/j.envres.2025.122097
Vancouver
Zhao H, Zhang Z, Yu H, Wu D, Wang H, Zhang X. Single-atom cobalt anchored biochar/PVDF membrane for antibiotic removal via coupling membrane filtration and sulfate-based advanced oxidation processes. Environmental Research. 2025;282:122097. doi:10.1016/j.envres.2025.122097
BibTeX
@article{Zhao2025,
author = {Zhao, Huanxin and Zhang, Zhihan and Yu, Huixin and Wu, Dan and Wang, He and Zhang, Xuejun},
title = {Single-atom cobalt anchored biochar/PVDF membrane for antibiotic removal via coupling membrane filtration and sulfate-based advanced oxidation processes},
journal = {Environmental Research},
year = {2025},
volume = {282},
pages = {122097},
doi = {10.1016/j.envres.2025.122097}
}
EUVIMED